missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies Everolimus
Description
- Everolimus is an inhibitor of the mammalian target of rapamycin (mTOR)
- It is a hydroxyethyl ether-substituted derivative of rapamycin with improved pharmacokinetic and pharmacodynamic properties
- It inhibits both mTORC1 and mTORC2 complexes by binding to FK506-binding protein (FKBP-12), which then binds to mTOR, leading to complex destabilization and blocked kinase function (Zeng et al.; Lebwohl et al.; Sedrani et al.; Huang & Houghton)
- Inhibits cell proliferation, metabolism, and angiogenesis in a variety of cancers using in vitro and in vivo models (Zhu et al.; Lane et al.; O'Reilly et al.; Lebwohl et al.)
- Acts as an immunosuppressive agent in the context of organ transplantation (Lebwohl et al.; Wullschleger et al.)
Specifications
Specifications
| CAS | 159351-69-6 |
| Synonym | RAD001; SDZ-RAD; Xience |
| Quantity | 25 mg |
| Molecular Formula | C53H83NO14 |
| Purity | ≥95% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?